Melanotan I goes by a few names: afamelanotide (its clinical name), MT1, and MT-1
In the SUSTAIN 6 trial, over 3,297 patients with type 2 diabetes with established chronic kidney disease and/or cardiovascular disease underwent randomization to semaglutide or placebo and were followed for 2 years resulting in a 26% risk reduction in the combined endpoint of rate of cardiovascular disease, nonfatal myocardial infarction, or nonfatal stroke [47]
Bypassing the digestive system, glutathione enters the body quickly and offers an instant increase in antioxidant levels
Alan Gaby, for instance, treated nearly 1,000 patients with IV vitamins over 16 years and found it safe and helpful for many health goals
Hormonal Regulation Peptides alter GnRH, LH, and FSH release of the HPG axis